Overview Single Ascending Oral Doses of SY-008 in Healthy Subjects Status: Completed Trial end date: 2018-12-30 Target enrollment: Participant gender: Summary This is a phase Ⅰ，single-center, randomized, double-blinded, placebo-controlled, single ascending dose trial of SY-008 in healthy subjects. Phase: Phase 1 Details Lead Sponsor: Suzhou Yabao Pharmaceutical R&D Co., Ltd.